ישראל - עברית - Ministry of Health

cts ltd - asparaginase - אבקה להכנת תמיסה לזריקה - asparaginase 10000 iu/vial - asparaginase - asparaginase - acute lymphoblastic leukemia, acute myeloblastic leukemia.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - estramustine phosphate 140 mg - capsules - estramustine - second line therapy in prostatic carcinoma in advanced stages.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - tretinoin - קפסולות - tretinoin 10 mg - tretinoin - tretinoin - induction of remission in acute promyelocytic leukemia.

ישראל - עברית - Ministry of Health

novartis israel ltd - topotecan as hydrochloride - אבקה להכנת תמיסה לאינפוזיה - topotecan as hydrochloride 4 mg/vial - topotecan - topotecan - treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy. treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. topotecan in combination with cisplatin is indicated for the treatment of stage iv-b recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

ישראל - עברית - Ministry of Health

novartis israel ltd - topotecan as hydrochloride - קפסולות ג'לטין קשיחות - topotecan as hydrochloride 0.25 mg - topotecan - topotecan - indicated for the treatment of patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.

ישראל - עברית - Ministry of Health

novartis israel ltd - topotecan as hydrochloride - קפסולות ג'לטין קשיחות - topotecan as hydrochloride 1 mg - topotecan - topotecan - indicated for the treatment of patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.

ישראל - עברית - Ministry of Health

devries & co. ltd - topotecan hydrochloride 1 mg - powder for concentrate for soution for infusion - topotecan - treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy. treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. topotecan in combination with cisplatin is indicated for the treatment of stage iv-b recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

ישראל - עברית - Ministry of Health

medison pharma ltd - topotecan hydrochloride 4 mg/vial - powder for concentrate for infusion - topotecan - treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy.treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. topotecan in combination with cisplatin is indicated for the treatment of stage iv-b recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - irinotecan hydrochloride - תמיסה לאינפוזיה - irinotecan hydrochloride 20 mg/ml - irinotecan - irinotecan - campto is indicated for the treatment of patients with metastatic colorectal cancer: in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.

ישראל - עברית - Ministry of Health

novapharma ltd - irinotecan (trihydrate) hydrochloride 20 mg/ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.